Prof Steve Conlan
Head of Innovation
Swansea Medical School
Steve is Head of Enterprise and Innovation in the Medical School, leading the development and delivery of innovation activities both from within the Medical School, and with external organisations including businesses and Wales NHS.
He has worked on large infrastructure projects, strategic national and international collaborations, and industrial partnerships. He was a founding Director of the £22 Million Centre for NanoHealth [CNH, nanohealth.swansea.ac.uk] at Swansea University, an interdisciplinary R&D facility delivering advances in nanomedicine. He is now Strategic Director of the Celtic Advanced Life Science Innovation Network [CALIN, calin.wales], a €12 Million Ireland-Wales INTERREG project building a life sciences innovation bridge between Wales (Bangor, Cardiff, Swansea) and Ireland (Cork, Dublin, Galway).
Steve is Professor of Molecular and Cell Biology, and leads the vibrant Reproductive Biology and Gynaecological Oncology research group [swansea.ac.uk/medicine/research/rbgo] in Swansea University Medical School.
Steve’s research and innovation interests are in the application of molecular, cellular and nano biology to understanding gynaecological pathologies including cancer and infertility. He has a particular interest in transcription and epigenetic processes, and advanced therapeutics (Antibody Drug Conjugates, exosomes, and nanoparticle deliver systems).
Steve is a Fellow of the Royal Society of Biology (FRSB), and a Trustee of the British Society of Nanomedicine. He is a Senior Affiliate Member of The Methodist Hospital Research Institute, Houston Texas, Distinguished Professor at Xi’an Jiaotong University, Suzhou Academy, China, and honorary consultant in the Abertawe Bro Morgannwg NHS Board.
- Advancing Therapeutic Developments Through Innovation Clusters
1 May 2019 12:10 pm